ADIL

Adial Pharmaceuticals
ADIL

Overview Fund Trends Analyst Outlook Journalist POV

16 hedge funds and large institutions have $491K invested in Adial Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
16
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$296K
2
+$43K
3
+$27.5K
4
TRCT
Tower Research Capital (TRC)
New York
+$7.88K
5
UBS Group
UBS Group
Switzerland
+$5.72K

Top Sellers

1
-$6
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$296K
2
$89.5K
3
$43K
4
$27.5K
5
$14.2K
6
$7.88K
7
$6.74K
8
$4.65K
9
$1.15K
10
$1.02K
11
$51
12
$34
13
$15
14
$15